{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T05:14:39Z","timestamp":1721452479824},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1097\/md.0000000000003371","type":"journal-article","created":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T18:33:10Z","timestamp":1462213990000},"page":"e3371","source":"Crossref","is-referenced-by-count":13,"title":["Relationship Among Chlamydia and Mycoplasma Pneumoniae Seropositivity, IKZF1 Genotype and Chronic Obstructive Pulmonary Disease in A General Japanese Population"],"prefix":"10.1097","volume":"95","author":[{"given":"Shigeo","family":"Muro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Tabara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisako","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Setoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimihiko","family":"Murase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikashi","family":"Terao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kosugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Chin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-64-20210309","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1378\/chest.130.6.1642","article-title":"Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities study","volume":"130","author":"Hozawa","year":"2006","journal-title":"Chest"},{"key":"R2-64-20210309","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1161\/01.CIR.0000037220.00065.0D","article-title":"Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins","volume":"106","author":"Engstr\u00f6m","year":"2002","journal-title":"Circulation"},{"key":"R3-64-20210309","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/eurjhf\/hfs016","article-title":"Airflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study","volume":"14","author":"Agarwal","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"R4-64-20210309","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.amjmed.2010.12.006","article-title":"Lung function and risk for heart failure among older adults: the Health ABC Study","volume":"124","author":"Georgiopoulou","year":"2011","journal-title":"Am J Med"},{"key":"R5-64-20210309","doi-asserted-by":"crossref","first-page":"e930","DOI":"10.1097\/MD.0000000000000930","article-title":"Increased risk of dementia in patients with chronic obstructive pulmonary disease","volume":"94","author":"Liao","year":"2015","journal-title":"Medicine"},{"key":"R6-64-20210309","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1097\/MD.0000000000000076","article-title":"Survival in COPD: impact of lung dysfunction and comorbidities","volume":"93","author":"Miniati","year":"2014","journal-title":"Medicine"},{"key":"R7-64-20210309","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/rccm.201007-1125OC","article-title":"Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults","volume":"183","author":"de Marco","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-64-20210309","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1136\/bmj.1.6077.1645","article-title":"The natural history of chronic airflow obstruction","volume":"1","author":"Fletcher","year":"1977","journal-title":"Br Med J"},{"key":"R9-64-20210309","doi-asserted-by":"crossref","first-page":"354S","DOI":"10.1378\/chest.117.5_suppl_2.354S","article-title":"The prevalence of COPD: using smoking rates to estimate disease frequency in the general population","volume":"117","author":"Stang","year":"2000","journal-title":"Chest"},{"key":"R10-64-20210309","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/thx.2005.052241","article-title":"Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study","volume":"61","author":"Brutsche","year":"2006","journal-title":"Thorax"},{"key":"R11-64-20210309","doi-asserted-by":"crossref","first-page":"e1503","DOI":"10.1097\/MD.0000000000001503","article-title":"Adipokine CTRP-5 as a potential novel inflammatory biomarker in chronic obstructive pulmonary disease","volume":"94","author":"Li","year":"2015","journal-title":"Medicine"},{"key":"R12-64-20210309","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejim.2009.05.006","article-title":"Chlamydophila pneumoniae infection and COPD: more evidence for lack of evidence?","volume":"20","author":"Papaetis","year":"2009","journal-title":"Eur J Intern Med"},{"key":"R13-64-20210309","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/ije\/25.3.658","article-title":"Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease","volume":"25","author":"von Hertzen","year":"1996","journal-title":"Int J Epidemiol"},{"key":"R14-64-20210309","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/thorax.57.8.672","article-title":"Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment","volume":"57","author":"Blasi","year":"2002","journal-title":"Thorax"},{"key":"R15-64-20210309","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.rmed.2004.04.014","article-title":"Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD","volume":"99","author":"Brand\u00e9n","year":"2005","journal-title":"Respir Med"},{"key":"R16-64-20210309","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s100960100596","article-title":"Chlamydia pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease: analysis of 250 hospitalizations","volume":"20","author":"Lieberman","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R17-64-20210309","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMra0800353","article-title":"Infection in the pathogenesis and course of chronic obstructive pulmonary disease","volume":"359","author":"Sethi","year":"2008","journal-title":"N Engl J Med"},{"key":"R19-64-20210309","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1164\/ajrccm.158.3.9711092","article-title":"Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma","volume":"158","author":"Kraft","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"R20-64-20210309","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ng.501","article-title":"Genome-wide association study identifies five loci associated with lung function","volume":"42","author":"Repapi","year":"2010","journal-title":"Nat Genet"},{"key":"R21-64-20210309","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/01.STR.0000018974.05768.FB","article-title":"Chlamydia pneumoniae seropositivity is associated with increased plasma levels of soluble cellular adhesion molecules in community-dwelling subjects: the Shimanami Health Promoting Program (J-SHIPP) study","volume":"33","author":"Kohara","year":"2002","journal-title":"Stroke"},{"key":"R22-64-20210309","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jcp.43.2.163","article-title":"Evaluation of Serodia Myco II particle agglutination test for detecting Mycoplasma pneumoniae antibody: comparison with mu-capture ELISA and indirect immunofluorescence","volume":"43","author":"Barker","year":"1990","journal-title":"J Clin Pathol"},{"key":"R23-64-20210309","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1099\/jmm.0.46402-0","article-title":"Seroprevalence of Mycoplasma pneumoniae in HIV-infected patients using a microparticle agglutination test","volume":"55","author":"Shankar","year":"2006","journal-title":"J Med Microbiol"},{"key":"R24-64-20210309","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7883\/yoken.JJID.2007.352","article-title":"Seroprevalence of Mycobacterium pneumoniae in healthy adolescents in Taiwan","volume":"60","author":"Kung","year":"2007","journal-title":"Jpn J Infect Dis"},{"key":"R25-64-20210309","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/sim.4004","article-title":"How to link call rate and p-values for Hardy-Weinberg equilibrium as measures of genome-wide SNP data quality","volume":"29","author":"Finner","year":"2010","journal-title":"Stat Med"},{"key":"R26-64-20210309","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/gepi.20303","article-title":"Estimation of the multiple testing burden for genomewide association studies of nearly all common variants","volume":"32","author":"Pe\u2019er","year":"2008","journal-title":"Genet Epidemiol"},{"key":"R27-64-20210309","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/gepi.20217","article-title":"Genetic model testing and statistical power in population-based association studies of quantitative traits","volume":"31","author":"Lettre","year":"2007","journal-title":"Genet Epidemiol"},{"key":"R28-64-20210309","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ng.472","article-title":"Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus","volume":"41","author":"Han","year":"2009","journal-title":"Nat Genet"},{"key":"R29-64-20210309","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/thorax.57.12.1087-a","article-title":"Chlamydia pneumoniae and COPD exacerbation","volume":"57","author":"Seemungal","year":"2002","journal-title":"Thorax"},{"key":"R30-64-20210309","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1164\/ajrccm.161.2.9904055","article-title":"Chlamydia pneumoniae serology, lung function decline, and treatment for respiratory disease","volume":"161","author":"Strachan","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R31-64-20210309","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1471-2458-10-306","article-title":"Population attributable fraction of smoking and metabolic syndrome on cardiovascular disease mortality in Japan: a 15-year follow up of NIPPON DATA90","volume":"10","author":"Takashima","year":"2010","journal-title":"BMC Public Health"},{"key":"R32-64-20210309","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1099\/jmm.0.003335-0","article-title":"Role of Mycoplasma pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease","volume":"58","author":"Varma-Basil","year":"2009","journal-title":"J Med Microbiol"},{"key":"R33-64-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0732-8893(02)00421-2","article-title":"Serological evidence of Mycoplasma pneumonia infection in acute exacerbation of COPD","volume":"44","author":"Lieberman","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R34-64-20210309","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1183\/09031936.00012707","article-title":"The role atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease","volume":"30","author":"Diederen","year":"2007","journal-title":"Eur Respir J"},{"key":"R35-64-20210309","first-page":"476","article-title":"A prospective study of infections with atypical pneumonia organisms in acute exacerbations of chronic bronchitis","volume":"28","author":"Goh","year":"1999","journal-title":"Ann Acad Med Singapore"},{"key":"R36-64-20210309","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1164\/rccm.200804-560OC","article-title":"Airflow limitation in smokers is associated with subclinical atherosclerosis","volume":"179","author":"Iwamoto","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R37-64-20210309","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/01.CIR.100.8.832","article-title":"Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis","volume":"100","author":"Markus","year":"1999","journal-title":"Circulation"},{"key":"R38-64-20210309","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/2047487312472078","article-title":"Chlamydia pneumoniae and progression of subclinical atherosclerosis","volume":"21","author":"Player","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"R39-64-20210309","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/bmj.318.7190.1035","article-title":"Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study","volume":"318","author":"Strachan","year":"1999","journal-title":"BMJ"},{"key":"R40-64-20210309","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/ng.2756","article-title":"Systematic identification of trans eQTLs as putative drivers of known disease associations","volume":"45","author":"Westra","year":"2013","journal-title":"Nat Genet"},{"key":"R41-64-20210309","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jaci.2014.12.1916","article-title":"IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome\/toxic epidermal necrolysis with severe mucosal involvement","volume":"135","author":"Ueta","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R42-64-20210309","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1016\/j.febslet.2005.07.018","article-title":"STAT4 is a target of the hematopoietic zinc-finger transcription factor Ikaros in T cells","volume":"579","author":"Yap","year":"2005","journal-title":"FEBS Lett"},{"key":"R43-64-20210309","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/382174a0","article-title":"Impaired IL-12 responses and enhance development of Th2 cells in Stat4-deficient mice","volume":"382","author":"Kaplan","year":"1996","journal-title":"Nature"},{"key":"R44-64-20210309","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R45-64-20210309","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1099\/jmm.0.020362-0","article-title":"Serological diagnosis of Chlamydia pneumoniae infection: limitations and perspectives","volume":"59","author":"Villegas","year":"2010","journal-title":"J Med Microbiol"},{"key":"R46-64-20210309","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/322632","article-title":"Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada)","volume":"33","author":"Dowell","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R47-64-20210309","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1378\/chest.06-2415","article-title":"Asthma and atypical bacterial infection","volume":"132","author":"Sutherland","year":"2007","journal-title":"Chest"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T05:03:50Z","timestamp":1718514230000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201604120-00064"}},"subtitle":["The Nagahama Study"],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":46,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003371","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}